VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,616 | -14.9% | 109,190 | +4.0% | 0.00% | – |
| Q3 2022 | $16,000 | +300.0% | 105,000 | +2000.0% | 0.00% | – |
| Q2 2022 | $4,000 | -33.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2022 | $6,000 | -76.9% | 5,000 | -62.3% | 0.00% | – |
| Q4 2021 | $26,000 | +73.3% | 13,265 | +147.9% | 0.00% | – |
| Q3 2021 | $15,000 | -6.2% | 5,351 | +7.0% | 0.00% | – |
| Q2 2021 | $16,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Performa Ltd (US), LLC | 4,900 | $9,163 | 0.01% |